Global Financial Private Client’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Global Financial Private Client's IBB Position: Q2 2025 in Review
Global Financial Private Client sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 2,601 shares — an estimated $333K sold.
Global Financial Private Client first reported a position in IBB in Q4 2019 and held it in 22 quarters. The position peaked at $661K in Q4 2022. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.
- Global Financial Private Client reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
- Global Financial Private Client sold 2,601 iShares Biotechnology ETF shares in Q2 2025, an estimated $333K.
- Global Financial Private Client first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 22 quarters.
- Global Financial Private Client's iShares Biotechnology ETF position peaked at $661K in Q4 2022.
- 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.
Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.